相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。SAMD4 family members suppress human hepatitis B virus by directly binding to the Smaug recognition region of viral RNA
Yuze Wang et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2021)
Role of serum HBV RNA and hepatitis B surface antigen levels in identifying Asian patients with chronic hepatitis B suitable for entecavir cessation
Wai-Kay Seto et al.
GUT (2021)
Restoring IL-2 to its cancer immunotherapy glory
Asher Mullard
NATURE REVIEWS DRUG DISCOVERY (2021)
Pegylated Interferon-α (IFN-α) Enhances the Inhibitory Effect of Natural Killer Cells on Regulatory T Cells via IFN-γ in Chronic Hepatitis B
Wei Yuan et al.
JOURNAL OF INFECTIOUS DISEASES (2021)
Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conferences
Markus Cornberg et al.
JOURNAL OF HEPATOLOGY (2020)
Sustained IFN-I stimulation impairs MAIT cell responses to bacteria by inducing IL-10 during chronic HIV-1 infection
X. Tang et al.
SCIENCE ADVANCES (2020)
Efficacy of a combination of HBV RNA and HBeAg in predicting HBeAg seroconversion in patients treated with entecavir for 144 weeks
Xiaomei Wang et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Immunomodulation Induced During Interferon-α Therapy Impairs the Anti-HBV Immune Response Through CD24+CD38hi B Cells
Binqing Fu et al.
FRONTIERS IN IMMUNOLOGY (2020)
Human FOXP3+ Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer
James B. Wing et al.
IMMUNITY (2019)
Shared and Distinct Functions of Type I and Type III Interferons
Helen M. Lazear et al.
IMMUNITY (2019)
Chronic stimulation drives human NK cell dysfunction and epigenetic reprograming
Aimee Merino et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Insights From Antiviral Therapy Into Immune Responses to Hepatitis B and C Virus Infection
Barbara Rehermann et al.
GASTROENTEROLOGY (2019)
Phenotypic and functional differences of HBV core-specific versus HBV polymerase-specific CD8+T cells in chronically HBV-infected patients with low viral load
Anita Schuch et al.
GUT (2019)
Regulatory NK cells mediated between immunosuppressive monocytes and dysfunctional T cells in chronic HBV infection
Haijun Li et al.
GUT (2018)
Hepatitis B virus-specific T cells associate with viral control upon nucleos(t)ide-analogue therapy discontinuation
Laura Rivino et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Perspectives and limitations for nucleo(t)side analogs in future HBV therapies
Massimo Levrero et al.
CURRENT OPINION IN VIROLOGY (2018)
PD-1 blockade partially recovers dysfunctional virus-specific B cells in chronic hepatitis B infection
Loghman Salimzadeh et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Biology and regulation of IL-2: from molecular mechanisms to human therapy
Rosanne Spolski et al.
NATURE REVIEWS IMMUNOLOGY (2018)
IL-2high tissue-resident T cells in the human liver: Sentinels for hepatotropic infection
Laura J. Pallett et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B
Paola Fisicaro et al.
NATURE MEDICINE (2017)
STAT5-mediated chromatin interactions in superenhancers activate IL-2 highly inducible genes: Functional dissection of the Il2ra gene locus
Peng Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Antiviral therapy for chronic hepatitis B viral infection in adults: A systematic review and meta-analysis
Anna S. F. Lok et al.
HEPATOLOGY (2016)
An essential role for the IL-2 receptor in Treg cell function
Takatoshi Chinen et al.
NATURE IMMUNOLOGY (2016)
Low-dose interleukin-2 treatment selectively modulates CD4+ T cell subsets in patients with systemic lupus erythematosus
Jing He et al.
NATURE MEDICINE (2016)
Regulatory T Cells in Hepatitis B and C Virus Infections
Min Kyung Jung et al.
IMMUNE NETWORK (2016)
Overview of the special issue on HBV immunity
Antonio Bertoletti et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2015)
Immunological Aspects of Antiviral Therapy of Chronic Hepatitis B Virus and Hepatitis C Virus Infections
Barbara Rehermann et al.
HEPATOLOGY (2015)
Interferon-Stimulated Genes: A Complex Web of Host Defenses
William M. Schneider et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 32 (2014)
Reduction of HBV replication prolongs the early immunological response to IFNα therapy
Anthony T. Tan et al.
JOURNAL OF HEPATOLOGY (2014)
Restoration of HBV-specific CD8+T cell function by PD-1 blockade in inactive carrier patients is linked to T cell differentiation
Bertram Bengsch et al.
JOURNAL OF HEPATOLOGY (2014)
Exosomes mediate the cell-to-cell transmission of IFN-α-induced antiviral activity
Jianhua Li et al.
NATURE IMMUNOLOGY (2013)
Blockade of Chronic Type I Interferon Signaling to Control Persistent LCMV Infection
Elizabeth B. Wilson et al.
SCIENCE (2013)
Interferon α-Stimulated Natural Killer Cells From Patients With Acute Hepatitis C Virus (HCV) Infection Recognize HCV-Infected and Uninfected Hepatoma Cells via DNAX accessory molecule-1
Kerstin A. Stegmann et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Modulation of cytokine receptors by IL-2 broadly regulates differentiation into helper T cell lineages
Wei Liao et al.
NATURE IMMUNOLOGY (2011)
Prognosis of Japanese Metastatic Renal Cell Carcinoma Patients in the Cytokine Era: A Cooperative Group Report of 1463 Patients
Sei Naito et al.
EUROPEAN UROLOGY (2010)
Interleukin-2 Receptor Signaling: At the Interface between Tolerance and Immunity
Thomas R. Malek et al.
IMMUNITY (2010)
Competing feedback loops shape IL-2 signaling between helper and regulatory T lymphocytes in cellular microenvironments
Dorothea Busse et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Virologic, serologic, and biochemical outcomes through 2 years of treatment with entecavir and lamivudine in nucleoside-naive Chinese patients with chronic hepatitis B: a randomized, multicenter study
Guangbi Yao et al.
HEPATOLOGY INTERNATIONAL (2008)
Specific immune response to HBsAg is enhanced by β-glucan oligosaccharide containing an α-(1 → 3)-linked bond and biased towards M2/Th2
Sheng-Fu Dong et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2007)
A function for interleukin 2 in Foxp3-expressing regulatory T cells
JD Fontenot et al.
NATURE IMMUNOLOGY (2005)
Peginterferon alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B
GKK Lau et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Acute phase HBV-specific T cell responses associated with HBV persistence after HBV/HCV coinfection
S Urbani et al.
HEPATOLOGY (2005)
Naturally arising Foxp3-expressing CD25+ CD4+ regulatory T cells in immunological tolerance to self and non-self
S Sakaguchi
NATURE IMMUNOLOGY (2005)
Frequencies of epitope-specific cytotoxic T lymphocytes in active chronic viral hepatitis B infection by using MHC class I peptide tetramers
YZ Wu et al.
IMMUNOLOGY LETTERS (2004)
Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo
JN Blattman et al.
NATURE MEDICINE (2003)
Virus-specific CD8+ lymphocytes share the same effector-memory phenotype but exhibit functional differences in acute hepatitis B and C
S Urbani et al.
JOURNAL OF VIROLOGY (2002)
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.
MW Fried et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
分享论文
